65 related articles for article (PubMed ID: 14696567)
1. FTC (emtricitabine, Emtriva).
Proj Inf Perspect; 2003 Oct; (36):6-7. PubMed ID: 14696567
[TBL] [Abstract][Full Text] [Related]
2. FDA notifications. NRTI Emtriva receives FDA approval.
AIDS Alert; 2003 Oct; 18(10):131-2. PubMed ID: 14686301
[TBL] [Abstract][Full Text] [Related]
3. Anti-HIV agents. Dueling nukes: AZT + 3TC vs. tenofovir + FTC.
TreatmentUpdate; 2005; 17(5):5-7. PubMed ID: 17225279
[No Abstract] [Full Text] [Related]
4. New questions about an old combination--ddI + d4T.
Proj Inf Perspect; 2003 Jan; (35):13-4. PubMed ID: 12647675
[TBL] [Abstract][Full Text] [Related]
5. Emtricitabine: a once-daily nucleoside reverse transcriptase inhibitor.
Modrzejewski KA; Herman RA
Ann Pharmacother; 2004 Jun; 38(6):1006-14. PubMed ID: 15121999
[TBL] [Abstract][Full Text] [Related]
6. Meeting notes from ICAAC. Tenofovir + emtricitabine vs. AZT + 3TC.
Feinberg J
AIDS Clin Care; 2005 Jan; 17(1):7. PubMed ID: 15717373
[No Abstract] [Full Text] [Related]
7. Antiretroviral activity of emtricitabine, a potent nucleoside reverse transcriptase inhibitor.
Richman DD
Antivir Ther; 2001 Jun; 6(2):83-8. PubMed ID: 11491420
[No Abstract] [Full Text] [Related]
8. Emtricitabine: new preparation. An antiretroviral very similar to lamivudine.
Prescrire Int; 2005 Apr; 14(76):54-6. PubMed ID: 15875341
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial toxicity of tenofovir, emtricitabine and abacavir alone and in combination with additional nucleoside reverse transcriptase inhibitors.
Venhoff N; Setzer B; Melkaoui K; Walker UA
Antivir Ther; 2007; 12(7):1075-85. PubMed ID: 18018766
[TBL] [Abstract][Full Text] [Related]
10. Tenofovir disoproxil fumarate-emtricitabine coformulation for once-daily dual NRTI backbone.
Muñoz de Benito RM; Arribas López JR
Expert Rev Anti Infect Ther; 2006 Aug; 4(4):523-35. PubMed ID: 17009933
[TBL] [Abstract][Full Text] [Related]
11. Relative mutagenic potencies of several nucleoside analogs, alone or in drug pairs, at the HPRT and TK loci of human TK6 lymphoblastoid cells.
Carter MM; Torres SM; Cook DL; McCash CL; Yu M; Walker VE; Walker DM
Environ Mol Mutagen; 2007; 48(3-4):239-47. PubMed ID: 17358029
[TBL] [Abstract][Full Text] [Related]
12. 3TC approval may revive AZT's appeal.
Vazquez E
Posit Aware; 1996; 7(1):8-9. PubMed ID: 11363136
[TBL] [Abstract][Full Text] [Related]
13. Emtriva gets approval.
AIDS Patient Care STDS; 2003 Sep; 17(9):484. PubMed ID: 14596254
[No Abstract] [Full Text] [Related]
14. In vitro evaluation of the anti-HIV activity and metabolic interactions of tenofovir and emtricitabine.
Borroto-Esoda K; Vela JE; Myrick F; Ray AS; Miller MD
Antivir Ther; 2006; 11(3):377-84. PubMed ID: 16759055
[TBL] [Abstract][Full Text] [Related]
15. [Approval of a new nucleoside. Component of complete once daily regimen].
MMW Fortschr Med; 2004 Apr; 146 Spec No 1():91. PubMed ID: 15373067
[No Abstract] [Full Text] [Related]
16. FDA notifications. Generic emtricitabine is approved by the FDA.
AIDS Alert; 2009 Feb; 24(2):21. PubMed ID: 19222147
[No Abstract] [Full Text] [Related]
17. Discovery and Development of the Anti-Human Immunodeficiency Virus Drug, Emtricitabine (Emtriva, FTC).
Liotta DC; Painter GR
Acc Chem Res; 2016; 49(10):2091-2098. PubMed ID: 27704821
[TBL] [Abstract][Full Text] [Related]
18. FTC (Emtriva) approved.
James JS
AIDS Treat News; 2003 Jul; (393):2-3. PubMed ID: 14679924
[TBL] [Abstract][Full Text] [Related]
19. [Improved long-term success. New nucleoside for once daily combinations].
MMW Fortschr Med; 2004 Apr; 146 Spec No 1():31-3. PubMed ID: 15373043
[No Abstract] [Full Text] [Related]
20. Emtricitabine, a new antiretroviral agent with activity against HIV and hepatitis B virus.
Saag MS
Clin Infect Dis; 2006 Jan; 42(1):126-31. PubMed ID: 16323102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
